BSD Medical Corp (BSDMC) [Rocket]

Overview

BSD Medical Corp (BSDMC)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
04/27/2017	15-12G	Form 15-12G - Securities registration termination [Section 12(g)]
01/25/2017	EFFECT	Form EFFECT - Notice of Effectiveness
01/25/2017	EFFECT	Form EFFECT - Notice of Effectiveness
01/25/2017	EFFECT	Form EFFECT - Notice of Effectiveness
01/12/2017	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
01/12/2017	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
01/12/2017	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-14	Aug-31-14	Dec-31-13	Aug-31-13	Dec-31-12	Aug-31-12	Dec-31-11	Aug-31-11
Revenues	1.1	7.6	1.7	5.2	2.1	3.0	3.0	4.4
Revenue growth	-33.7%	45.2%	-18.7%	75.6%	-31.8%	-33.3%		55.7%
Cost of goods sold	0.6	2.9	0.8	2.3	1.5	1.5	1.7	1.7
Gross profit	0.5	4.7	0.9	2.9	0.6	1.5	1.3	2.7
Gross margin	46.6%	61.8%	52.1%	56.6%	26.8%	48.9%	43.6%	61.5%
Selling, general and administrative	2.8	7.3	2.2	7.4	6.2	6.2	5.2	5.2
Research and development	0.6		0.7		2.4		1.5
EBITA	-3.7	-7.1	-2.1	-8.3	-8.0	-8.0	-5.3	-5.3
EBITA margin	-334.4%	-94.5%	-125.3%	-158.7%	-386.9%	-269.4%	-176.1%	-119.7%
Amortization of intangibles				0.0		0.0		0.0
EBIT	-3.7	-7.1	-2.1	-8.3	-8.0	-8.0	-5.3	-5.3
EBIT margin	-334.4%	-94.5%	-125.3%	-158.8%	-386.9%	-270.1%	-176.1%	-120.3%
Pre-tax income	-3.8	-7.1	-2.1	-8.2	-8.0	-8.0	-5.3	-5.3
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Net margin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Diluted EPS	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Shares outstanding (diluted)	39.7	35.0	34.0	31.4	29.7	29.7	28.8	28.8

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.